Favipiravir

CHEMBL221722 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

157.1 g/mol

LogP

-0.6

Phase

4

This antiviral medication blocks the enzyme that influenza viruses and some other RNA viruses use to copy their genetic material. It has been studied and used for influenza and certain other viral infections in some countries.

Masse moléculaire

157,1000 g/mol

LogP

-0,60

TPSA

84,60 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Infectious Disease Gastroesophageal Reflux Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

NC(=O)c1nc(F)cnc1O

InChI

InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)

Molecular Formula

C5H4FN3O2

HBD / HBA

2 / 4

Liaisons Rotatives

1

Atomes Lourds

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This antiviral medication blocks the enzyme that influenza viruses and some other RNA viruses use to copy their genetic material. It has been studied and used for influenza and certain other viral infections in some countries.

Yes, Favipiravir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL221722. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 492405. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Favipiravir sur PillFYI

Structure

Données Clés

Formule: C5H4FN3O2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.